Early-stage
biotech and
digital health
investors

We are a
strategic
venture fund
Who we are

We are investors in top tier biotherapeutic and digital health entrepreneurs who focus on helping patients and transforming the healthcare system.

What we do

We act similarly to institutional venture capitalists; we have the ability to lead, co-lead, or seed companies. We partner with management on their boards and make equity investments.

Our raison d'être

We provide a low-cost, self-sustaining vehicle enabling our parent company to engage with the early stage innovation ecosystem when companies are too risky or early to in-license or acquire.

Our Team

We love to meet entrepreneurs and hear about what they are doing. Feel free to reach out to us…

Our Portfolio
Strategic Wins
i2O Therapeutics Announces Research Collaboration with Sanofi to Enable Oral Delivery of Nanobody-Based Medicines
Kymera Therapeutics and Sanofi Enter into Strategic Partnership to Advance Novel Protein Degrader Therapies to Patients
Sanofi and Aetion launch enterprise-wide collaboration to advance regulatory submissions using real-world evidence
Science 37 and Sanofi Introduce a New Partnership
Sanofi Pasteur and Immune Design Enter Broad Collaboration for the Development of a Herpes Simplex Virus Therapy
Sanofi Licenses Immune Design's GLAAS Platform to Explore Novel Approach to Treat Food Allergy